QDEL Long Call Strategy

QDEL (QuidelOrtho Corporation), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.

QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems.

QDEL (QuidelOrtho Corporation) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $1.01B, a beta of 0.69 versus the broader market, a 52-week range of 9.92-35.58, average daily share volume of 2.0M, a public-listing history dating back to 1991, approximately 7K full-time employees. These structural characteristics shape how QDEL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.69 indicates QDEL has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on QDEL?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

QDEL snapshot

As of August 14, 2026, spot at $14.13, ATM IV 72.10%, IV rank 17.82%, expected move 20.67%. The long call on QDEL below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this long call structure on QDEL specifically: QDEL IV at 72.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a QDEL long call, with a market-implied 1-standard-deviation move of approximately 20.67% (roughly $2.92 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated QDEL expiries trade a higher absolute premium for lower per-day decay. Position sizing on QDEL should anchor to the underlying notional of $14.13 per share and to the trader's directional view on QDEL stock.

QDEL long call setup

The QDEL long call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With QDEL at $14.13 on that close, the first option leg uses a $14.13 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed QDEL chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 QDEL shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$14.13N/A

QDEL long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

QDEL long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on QDEL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on QDEL

Long calls on QDEL express a bullish thesis with defined risk; traders use them ahead of QDEL catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

QDEL thesis for this long call

The market-implied 1-standard-deviation range for QDEL extends from approximately $11.21 on the downside to $17.05 on the upside. A QDEL long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current QDEL IV rank near 17.82% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on QDEL at 72.10%. As a Healthcare name, QDEL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to QDEL-specific events.

QDEL long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. QDEL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move QDEL alongside the broader basket even when QDEL-specific fundamentals are unchanged. Long-premium structures like a long call on QDEL are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current QDEL chain quotes before placing a trade.

Frequently asked questions

What is a long call on QDEL?
A long call on QDEL is the long call strategy applied to QDEL (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With QDEL stock at $14.13 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed QDEL chain strike and the premiums come straight from that session's bid/ask midpoint.
How are QDEL long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the QDEL long call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 72.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a QDEL long call?
The breakeven for the QDEL long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The QDEL market-implied 1-standard-deviation expected move in the same options snapshot is approximately 20.67%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on QDEL?
Long calls on QDEL express a bullish thesis with defined risk; traders use them ahead of QDEL catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current QDEL implied volatility affect this long call?
QDEL ATM IV is at 72.10% with IV rank near 17.82%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related QDEL analysis